AstraZeneca Acquires Acerta Pharma for $4,000,000,000

  • Feed Type
  • Date
    12/17/2015
  • Company Name
    Acerta Pharma
  • Mailing Address
    1509 Industrial Rd. San Carlos, CA 94070 USA
  • Company Description
    Acerta Pharma B.V. offers drug discovery and development services for oncology and autoimmune diseases. The company is based in Oss, the Netherlands.
  • Website
    http://www.acerta-pharma.com
  • Transaction Type
    M&A
  • Transaction Amount
    $4,000,000,000
  • Transaction Round
  • Proceeds Purposes
  • M&A Terms
    AstraZeneca is to buy 55 percent of privately held biotech firm Acerta Pharma for $4 billion to give it access to a new kind of blood cancer drug, boosting its long-term growth at the cost of a near-term hit to earnings.

Trending on Xconomy